Terry Dagnon, Chief Operations Officer at Outlook Therapeutics, Inc. (OTLK), sold 520,000 shares at $1.14 ($593K) on 2023-04-20, disclosed to the SEC on 2023-04-21.
Open-market sale of $593k OTLK by Chief Operations Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| OTLK | BUY | 2021-12-03 | $14K | — | Filing → |
| OTLK | SELL | 2021-02-25 | $33K | — | Filing → |
| OTLK | SELL | 2021-02-17 | $162K | — | Filing → |